TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
MANE

Veradermics, Incorporated

Healthcare · Biotechnology

121.20$ +2.9% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Veradermics, Incorporated (MANE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 826 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MANE
Line item Q4 24 Q3 25 Q4 25 Q1 26 Q2 26
59 19 153 399 826
56 19 152 397 825
53 5.7 22 168 319
53 15 142 391 820
1.4 1.2 1.3 1.7 –
4.7 115 274 6.7 12
4.7 5.7 9.2 6.7 12
2.2 2.0 2.1 1.1 5.9
55 -96 -121 392 814
-49 -97 -123 -151 -174
201 35 37 37 40

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?